Answers are grounded in this paper and cite their sources.
Objective: might decrease pain thus improving joint function. Methods: efficacy for knee OA. We reported mean differences (MD) with 95% confidence interval (CI) for continuous outcomes and evaluated Visual Analog Scale (VAS) for pain and the Western Ontario and McMaster Universities Arthritis Index (WOMAC) total score over 4 to 6 weeks for treatment effects. Results: demonstrated similar improvement in VAS for pain compared to placebo (MD 27.02, 95% CI 1.45 to 52.60, p=0.04; MD 21.48, 95% CI 1.78 to 41.18, p=0.03). Conclusion: as therapeutic option for knee OA.
No takes yet. Share an insight, caveat, or question.
Hidayat et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: